Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brenner

Showing results (691-700 of 989) with videos related to

Pageof 99
Sort By:
American Journal of Preventive Medicine|September 25, 2007
Creating a model program for influenza surveillance in California: results from the 2005-2006 influenza seasonJanice K Louie, David P Schnurr, Hugo F Guevara, et al.
Human Mutation|February 19, 2000
Fifteen new mutations (-195C>T, L-12X, 298-2A>G, T117N, A159T, R229S, 997+2T>A, E274X, A331T, H364R, D389G, 1256delC, R433H, N461I, C472S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in patients with hypophosphatasiaA Taillandier, E Cozien, F Muller, et al.
Clinical Genitourinary Cancer|October 14, 2025
CABOSEQ 3-Comparison of Cabozantinib versus Sunitinib Following First-Line Nivolumab- Ipilimumab for Metastatic Renal Cell Carcinoma: A Target Trial Emulation Using Real-World Data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)Audreylie Lemelin, David Maj, Kosuke Takemura, et al.
BMJ Open|August 18, 2021
Adverse events associated with endoscopic retrograde cholangiopancreatography: protocol for a systematic review and meta-analysisNauzer Forbes, Grigorios I Leontiadis, Marcus Vaska, et al.
Journal of the Canadian Association of Gastroenterology|April 30, 2026
Should we screen for colorectal cancer with biennial FIT beginning at age 45 in Canada?Linda Rabeneck, Jill Tinmouth, John M Hutchinson, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft versus Leukemia Response with Adoptive Cellular TherapyKatie Maurer, Cameron Y Park, Shouvik Mani, et al.
Gut|January 8, 2021
Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriersPeter Georgeson, Bernard J Pope, Christophe Rosty, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021Eliya Farah, Maria El Bizri, Radmila Day, et al.
Gastroenterology|November 8, 2024
Adverse Events Associated With Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-AnalysisKirles Bishay, Zhao Wu Meng, Rishad Khan, et al.
The Journal of Molecular Diagnostics : JMD|November 17, 2022
Evaluating Multiple Next-Generation Sequencing-Derived Tumor Features to Accurately Predict DNA Mismatch Repair StatusRomy Walker, Peter Georgeson, Khalid Mahmood, et al.
Pageof 99

Showing results (691-700 of 989) with videos related to

Sort By:
Pageof 99
American Journal of Preventive Medicine|September 25, 2007
Creating a model program for influenza surveillance in California: results from the 2005-2006 influenza seasonJanice K Louie, David P Schnurr, Hugo F Guevara, et al.
Human Mutation|February 19, 2000
Fifteen new mutations (-195C>T, L-12X, 298-2A>G, T117N, A159T, R229S, 997+2T>A, E274X, A331T, H364R, D389G, 1256delC, R433H, N461I, C472S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in patients with hypophosphatasiaA Taillandier, E Cozien, F Muller, et al.
Clinical Genitourinary Cancer|October 14, 2025
CABOSEQ 3-Comparison of Cabozantinib versus Sunitinib Following First-Line Nivolumab- Ipilimumab for Metastatic Renal Cell Carcinoma: A Target Trial Emulation Using Real-World Data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)Audreylie Lemelin, David Maj, Kosuke Takemura, et al.
BMJ Open|August 18, 2021
Adverse events associated with endoscopic retrograde cholangiopancreatography: protocol for a systematic review and meta-analysisNauzer Forbes, Grigorios I Leontiadis, Marcus Vaska, et al.
Journal of the Canadian Association of Gastroenterology|April 30, 2026
Should we screen for colorectal cancer with biennial FIT beginning at age 45 in Canada?Linda Rabeneck, Jill Tinmouth, John M Hutchinson, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft versus Leukemia Response with Adoptive Cellular TherapyKatie Maurer, Cameron Y Park, Shouvik Mani, et al.
Gut|January 8, 2021
Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriersPeter Georgeson, Bernard J Pope, Christophe Rosty, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021Eliya Farah, Maria El Bizri, Radmila Day, et al.
Gastroenterology|November 8, 2024
Adverse Events Associated With Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-AnalysisKirles Bishay, Zhao Wu Meng, Rishad Khan, et al.
The Journal of Molecular Diagnostics : JMD|November 17, 2022
Evaluating Multiple Next-Generation Sequencing-Derived Tumor Features to Accurately Predict DNA Mismatch Repair StatusRomy Walker, Peter Georgeson, Khalid Mahmood, et al.
Pageof 99